To add a bio or update investment portfolio click update information.
Sovereign AI
Investment Portfolio


CuspAI announces £335m Series B led by Kleiner Perkins and NEA to design new semiconductor, energy and advanced manufacturing materials
CuspAI builds an agentic AI platform, MIRA, that designs new materials to order, running the full cycle from generative design through simulation, synthesis planning and coordinated lab validation. The platform serves industrial and government R&D teams in semiconductors, clean energy and advanced manufacturing, where the materials needed for next-generation products do not yet exist.


Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.


Ineffable Intelligence lands over £800m in a seed round led by Sequoia and Lightspeed to develop superintelligence with reinforcement learning
Ineffable Intelligence is an AI research startup developing systems that learn from their own experience to discover new knowledge. It focuses on building a “superlearner” designed to advance reinforcement learning and scientific discovery.
More venture news
- 28 Jul 2026


Dwelly lands £130m in funding led by EQT Growth and General Catalyst to acquire and run independent lettings agencies on shared AI infra
Series BProperty - 20 Jul 2026

CuspAICuspAI announces £335m Series B led by Kleiner Perkins and NEA to design new semiconductor, energy and advanced manufacturing materials
Series BDeep Tech - 16 Jul 2026

Risk LedgerRisk Ledger unlocks £24m Series B led by Axiom Equity to deliver network-first supply chain security platform
Series BCybersecurity